Evaluation of the Aulea Veloxion™ Disposable Resectoscope System for Operational Efficiency in Surgical Management of Benign Prostatic Hyperplasia (BPH)

Starting soon · Not applicable

Conditions studied: BPH (Benign Prostatic Hyperplasia)

In brief

Prospective, single-arm, single-site, post-market device study; all procedures use Veloxion™ per IFU.

Key facts

Study ID

NCT07728071

Run by

Chinese University of Hong Kong

People needed

20

Starts

2026-07-16

Expected to finish

2027-12-31

Last updated by the study team

2026-08-03

Who can join

Age: 30 and older, up to 70. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Age 30-70 years old with symptomatic BPH.
• Prostate volume 20-120 mL (TRUS/MRI/US)
• Suitable for endoscopic resection/vaporization per device IFU.
• Able to consent and comply with follow-up to 1 month.

You may not qualify if…

• Known/suspected prostate cancer requiring oncologic management.
• Prior prostate surgery impacting urethral anatomy within 12 months.
• Prior implant affecting urethral anatomy.
• Active UTI or untreated bacteriuria pre-op.
• Uncorrectable coagulopathy; inability to manage antithrombotics.
• Severe medical comorbidity precluding anesthesia or endoscopy.

Where it is running

• Prince of Wales Hospital — Shatin, Hong Kong

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.